Corrigendum to ‘Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients [European Journal of Cancer 163 (2022) 128–139] von Karsten, Maria M., Roehle, Robert, Albers, Sarah, Pross, Therese, Hage, Anna M., Weiler, Karoline, Fischer, Felix, Rose, Matthias, Kühn, Friedrich, Blohmer, Jens-Uwe

Volltext

Corrigendum to ‘The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer’ [European Journal of Cancer 154 (2021) 175-189] von Le Du, Fanny, Dièras, Véronique, Curigliano, Giuseppe

Volltext

Peer Review Policy for the European Journal of Cancer (EJC)

Volltext

Peer Review Policy for the European Journal of Cancer (EJC)

Volltext

Peer Review Policy for the European Journal of Cancer (EJC)

Volltext

Corrigendum to ‘Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review [European Journal of Cancer 184 (2023) 83–105] von Lai-Kwon, Julia, Inderjeeth, Andrisha-Jade, Lisy, Karolina, Sandhu, Shahneen, Rutherford, Claudia, Jefford, Michael

Volltext

Corrigendum to ‘Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial’. [European Journal of Cancer 137 (2020) 250–259] von Stahler, Arndt, Stintzing, Sebastian, von Einem, Jobst C., Westphalen (Benedikt), Christoph B., Heinrich, Kathrin, Krämer, Nicole, Michl, Marlies, Modest, Dominik P., Fischer von Weikersthal, Ludwig, Decker, Thomas, Kiani, Alexander, Heintges, Tobias, Kahl, Christoph, Kullmann, Frank, Scheithauer, Werner, Moehler, Markus, Kaiser, Florian, Kirchner, Thomas, Jung, Andreas, Heinemann, Volker

Volltext

Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’” [European Journal of Cancer 135 (2020) 1-7] von Benedikt Westphalen, C., Bokemeyer, Carsten, Büttner, Reinhard, Fröhling, Stefan, Gaidzik, Verena I., Glimm, Hanno, Hacker, Ulrich T., Heinemann, Volker, Illert, Anna L., Keilholz, Ulrich, Kindler, Thomas, Kirschner, Martin, Schilling, Bastian, Siveke, Jens T., Schroeder, Thomas, Tischler, Verena, Wagner, Sebastian, Weichert, Wilko, Zips, Daniel, Loges, Sonja, Bargou (Würzburg), Ralf, Bläker (Leipzig), Hendrik, Börries (Freiburg), Melanie, Brandts (Frankfurt), Christian, von Bubnoff (Freiburg), Nikolas, Demes (Frankfurt), Melanie, Desuki (Mainz), Alexander, Döhner (Ulm), Hartmut, Duyster (Freiburg), Justus, Gaisa (Aachen), Nadine, Heine (Bonn), Annkristin, Heining (Dresden), Christoph, Horak (Heidelberg), Peter, Jelas (Berlin), Ivan, Jost (München), Philipp J., Jung (München), Andreas, Kirchner (München), Thomas, Klauschen (Berlin), Frederick, Kreutzfeldt (Heidelberg), Simon, Kumbrink (München), Jörg, Kunzmann (Würzburg), Volker, Lassmann (Freiburg), Silke, Metzeler (München), Klaus, Möller (Ulm), Peter, Ortiz-Brüchle (Aachen), Nadina, Paret (Mainz), Claudia, Pelusi (Bonn), Natalie, Peters (Freiburg), Christoph, Pfarr (München), Nicole, Richter (Dresden), Daniela, Riedmann (München), Kristina, Rieke (Berlin), Damian, Ritzel (Mainz), Christoph, Schadendorf (Essen), Dirk, Schildhaus (Essen), Hans-Ulrich, Schorle (Bonn), Hubert, Seufferlein (Ulm), Thomas, Simon (Hamburg), Ronald, Stenzinger (Heidelberg), Albrecht, Tabatabai (Tübingen), Ghazaleh, Velthaus (Hamburg), Janna-Lisa, Werner (Freiburg), Martin, Wild (Frankfurt), Peter J., Wolf (Köln), Jürgen

Volltext

Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] von Fazio, Nicola, Gervaso, Lorenzo, Halfdanarson, Thorvardur R., La Salvia, Anna, Hofland, Johannes, Hernando, Jorge, Sonbol, Mohamad B., Garcia-Carbonero, Rocio, Capdevila, Jaume, de Herder, Wouter W., Koumarianou, Anna, Kaltsas, Gregory, Rossi, Maura, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Boselli, Sabrina, Tamayo, Darina, Bagnardi, Vincenzo, Laffi, Alice, Rubino, Manila, Spada, Francesca

Volltext

Corrigendum to ‘Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)’ [European Journal of Cancer 152 (2021) 116-128] von Gogas, Helen, Dummer, Reinhard, Ascierto, Paolo A., Arance, Ana, Mandalà, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsová, Ivana, Gutzmer, Ralf, Chiarion Sileni, Vanna, Dutriaux, Caroline, Yamazaki, Naoya, Loquai, Carmen, Queirolo, Paola, de Willem, Groot J., Sellier, Abir T., Suissa, Jeanne, Murris, Juliette, Gollerkeri, Ashwin, Robert, Caroline, Flaherty, Keith T.

Volltext

Peer Review Policy for the European Journal of Cancer (EJC)

Volltext

Peer Review Policy for the European Journal of Cancer (EJC)

Volltext

Erratum to ‘Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial’ [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101] von Hammel, Pascal, Portales, Fabienne, Mineur, Laurent, Metges, Jean-Philippe, Andre, Thierry, De La Fouchardiere, Christelle, Louvet, Christophe, El Hajbi, Farid, Faroux, Roger, Guimbaud, Rosine, Tougeron, David, Bouche, Olivier, Lecomte, Thierry, Rebischung, Christine, Tournigand, Christophe, Cros, Jerome, Kay, Richard, Hamm, Adam, Gupta, Anu, Bachet, Jean-Baptiste, El Hariry, Iman

Volltext

Erratum to ‘Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database’ [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163] von Delanoy, Nicolas, Hardy-Bessard, Anne-Claire, Efstathiou, Eleni, Moulec, Sylvestre Le, Basso, Umberto, Birtle, Alison, Thomson, Alastair, Krainer, Michael, Guillot, Aline, Giorgi, Ugo De, Hasbini, Ali, Daugaard, Gedske, Bahl, Amit, Chowdhury, Simon, Caffo, Orazio, Beuzeboc, Philippe, Spaeth, Dominique, Eymard, Jean-Christophe, Fléchon, Aude, Alexandre, Jerome, Helissey, Carole, Butt, Mohamed, Priou, Frank, Lechevallier, Eric, Deville, Jean-Laurent, Gross-Goupil, Marine, Morales, Rafael, Thiery-Vuillemin, Antoine, Gavrikova, Tatiana, Barthélémy, Philippe, Sella, Avishay, Fizazi, Karim, Ferrero, Jean-Marc, Laguerre, Brigitte, Thibault, Constance, Hans, Sophie, Oudard, Stéphane

Volltext

The European Journal of Cancer Prevention special issue on ‘Joining forces for better cancer registration in Europe’: achievements and perspectives von Randi, Giorgia, La Vecchia, Carlo

Volltext

Tibolone is not an oestrogen but a mixture of a strong progestin and two weak oestrogens: Comment on a paper by Johanna Simin et al, European Journal of Cancer 2017; 84:60–68 von Coelingh Bennink, Herjan JT

Volltext

Corrigendum to ‘Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)’ [European Journal of Cancer 169 (2022) 1–9] von Li, Jiarui, Cheng, Yuejuan, Bai, Chunmei, Xu, Jianming, Shen, Lin, Li, Jie, Zhou, Zhiwei, Li, Zhiping, Chi, Yihebali, Yu, Xianjun, Li, Enxiao, Xu, Nong, Liu, Tianshu, Lou, Wenhui, Bai, Yuxian, Yuan, Xianglin, Wang, Xiuwen, Yuan, Ying, Chen, Jia, Guan, Sha, Fan, Songhua, Su, Weiguo

Volltext

Corrigendum to ‘Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer’ [European Journal of Cancer 76 (2017) 36–44] von Massard, Christophe, Chi, Kim Nguyen, Castellano, Daniel, de Bono, Johann, Gravis, Gwenaelle, Dirix, Luc, Machiels, Jean-Pascal, Mita, Alain, Mellado, Begoña, Turri, Sabine, Maier, Joan, Csonka, Denes, Chakravartty, Arunava, Fizazi, Karim

Volltext

RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144–152 von Ronckers, Cecile M., Tytgat, Lieve, van den Heuvel-Eibrink, Marry M., Teepen, Jop, Kremer, Leontine C.M., Clement, Sarah, van Santen, Hanneke M.

Volltext

Corrigendum to “Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group” [European Journal of Cancer. Volume 140, November 2020, Pages 1-10] von Ditto, Antonino, Casarin, Jvan, Pinelli, Ciro, Perrone, Anna M., Scollo, Paolo, Martinelli, Fabio, Bogani, Giorgio, Leone Roberti Maggiore, Umberto, Signorelli, Mauro, Chiappa, Valentina, Giorda, Giorgio, Scibilia, Giuseppe, De Iaco, Pierandrea, Evangelista, Mariateresa, Ghezzi, Fabio, Paolini, Biagio, Lo Vullo, Salvatore, Mariani, Luigi, Montone, Rosanna, Raspagliesi, Francesco

Volltext